Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi

We are living in an age of massive medical innovation including a lot of new modalities especially in the area of ATMPs, but also beyond. Within this area, but obviously also beyond, there are core questions in the area of tensions such as the followings:

- What are the differences between Clinical Development and Medical Affairs?

- When should a company start telling their medical story about a new product?

- What are the differences between drugs and vaccinations from a medical affairs’ perspective?

- And how should market access and medical affairs ideally work together?

Market access veteran Dr. Stefan Walzer and Dr. Mike Rosenblatt, one of the pioneers in Medical Affairs, Commercialisation and Market Access continued their come together in Boston in May 2023 in this epic podcast episode. 

Don’t miss this amazing conversation. 

✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb

MAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #medicalaffairs #pricingstrategy #negotiations

#pricing #medtech #pharmaceuticals #usa #innovation #vaccination 

🎧 Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi  

🇨🇭Switzerland has one of the highest healthcare spendings per person across the world! At the same time, one could also say that Switzerland has also one of the best healthcare systems... 

💥 … but health care expert Dr. Peter Intra calls it still a developing country in terms of digitalisation! In this MAP podcast episode, health care system veteran Dr. Stefan Walzer and Dr. Peter Intra are discussing the current state of digital health in Switzerland, possible improvements and the inspiring example of Estonia.

What are we talking about, when we address the topic of digitalisation and e-health?

1. Data + AI, which is dealing with the data
2. Infrastructure like electronic patient record and vaccination registries
3. Processes 

Don't miss this inspiring conversation with spill-overs for all countries around the world. 

✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb

MAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #digitization #digitalhealth #funding #ehealth #healthcare #digitalisation #healthservices #switzerland

Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi

Companies, including start-ups, are usually focused solely on the development of the product and/or the technical platform in the early days. As understandable and important these aspects are, if they don’t start to think about their public communications strategy from the very beginning, they might be in danger of failing.                                                           

Already in the very early stages of the development of pharmaceuticals or med tech products, companies need to think about the following key points: 

Will patients need and want the new product?

Will physicians prescribe it?

Will payers pay for it?

And thus they should come up with a convincing value story towards all stakeholders as only if they could convince all of these, investors will see the potential return of investment! But ultimately, all of that needs to be communicated… The reimbursement veteran Dr. Stefan Walzer these and more aspects around (global and local) communication with the communication expert Dr. Arne Näveke. 

✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb

MAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #medtech #pharmaceuticals #communications #funding #medicaldevices #germany